History of MediciGlobal

With nearly two decades delivering outstanding results, MG is a world leader serving the global Life Sciences industry and a preferred provider to many biotech and pharmaceutical companies.

MediciGlobal is a patient recruitment-retention specialty firm serving the clinical trials industry. Liz Moench’s founding vision in 1991 was to create a company that addressed the primary cause of clinical trial delays: ineffective patient recruitment.

As an industry pioneer, Liz Moench introduced the first direct-to-consumer advertising programme for a prescription drug, and nearly a decade later launched the first patient recruitment programme for an oncology trial. The company continues to lead the industry in developing innovative patient recruitment programmes around the globe.

    1991

  • MediciGlobal founded under the name MediciGroup.

    • 1992

  • MediciGlobal utilises video news releases and patient advocacy for paediatric and adult epilepsy studies and orphan disease (CIDP).

    • 1993

  • MediciGlobal launches the first industry workshops on patient recruitment for the Drug Information Association (DIA).

    • 1995

  • MediciGlobal implements CTIP® (Clinical Trials Implementation Planning) workshops to prepare sites for recruitment and retention strategies for several complex studies. These were conducted for a major biotech company and a major global pharma company. Company expands to 7 people.
  • MediciGlobal presents paper at How to Market Healthcare Products on the Internet conference.

    • 1996

  • MediciGlobal builds first study Websites in support of patient recruitment. Company expands to 9 people.
  • MediciGlobal starts DIA (Drug Information Association) conferences for Patient Recruitment.

    • 1997

  • MediciGlobal publishes first industry forecasting model (the Leaky Pipe aka The Recruitment Funnel).

    • 1998

  • MediciGlobal expands into new offices and the team continues to grow.

    • 2001

  • MediciGlobal launches global recruitment-retention programme.

    • 2002

  • MediciGlobal launches SCORE™; Study Coordinator Recognition Programme for a major Pharma company’s pivotal oncology study.

    • 2003

  • Moves corporate headquarters to dedicated office building.
  • MediciGlobal brings phone pre screening in-house. Company expands to 20 people.
  • Graphic design is brought in-house. Company expands to 26 people.

    • 2006

  • MediciGlobal launches Study Coordinator Web Portal for 24/7 access to information for recruitment-retention management: www. StudyCoordinator.net. Company expands to 30 people.
  • MediciGlobal launches Study Sponsor Web Portal for 24/7 access to information for recruitment-retention management: http://www.StudySponsor.net. Company expands to 35 people.

    • 2007

  • European office opens. Company expands to 42 people.
  • MediciGlobal launches global recruitment technology: ADapt™.
  • MediciGlobal is voted number 1 by study coordinators.
  • MediciGlobal builds patient advocacy and guerrilla marketing team. Company expands to 45 people.

    • 2008

  • MediciGlobal brings public relations in-house.
  • MediciGlobal builds viral marketing team and expands to 50 plus full time team members.
  • EMEA orders a major Pharma Company (and Medici client) to withdraw its product from the market. The company removes the product from 47 countries. MediciGlobal adjusts headcount as a result of this regulatory decision and the loss of two global studies and one domestic one.

    • 2009

  • ADapt™ 2.0 is released with improved features on functionality, speed, and global tracking and stats on global use, with several thousand documents culturally adapted for use.
  • MediciGlobal CEO chairs the first annual Europe conference on Patient Recruitment and Retention in Amsterdam organised by Alan Lloyds.
  • MediciGlobal hires Martin Collyer as its COO to further enhance MediciGlobal’s global systems and processes.
  • MediciGlobal launches Head Start to Recruitment™, an innovative process delivering patient-centric feasibility, and ‘living databases’ of patients interested in clinical trial participation; real-time-databases with current-up to date information.

    • 2010

  • MediciGlobal CEO chairs the second annual Europe conference on Patient Recruitment and Retention in Amsterdam organised by Alan Lloyds.
  • MediciGlobal is interviewed by US newspaper, The Wall Street Journal, for a supplement on clinical trials.
  • MediciGlobal surveys 800 study coordinators for feedback on the design and release of its next version of http://www.StudyCoordinator.net, MediciGlobal’s Recruitment-Retention Online Management Portal.
  • MediciGlobal CEO accepts invitation to lecture on Patient Recruitment and Retention to students in clinical research in India.
  • MediciGlobal’s Global eMarketing Director selected as a PharmaVoice100 award recipient for innovation in further developing MediciGlobal’s Head Start to Recruitment™ process and global eMarketing outreach for patient recruitment programmes.
  • MediciGlobal expands its focus in patient enrollment for rare diseases and supports the efforts of small venture backed biotech companies.

    • 2011

  • MediciGlobal CEO chairs the third annual Europe conference on Patient Recruitment and Retention in Amsterdam, organised by Alan Lloyds.
  • MediciGlobal CEO will speak at the Patient Recruitment Outsourcing Conference in Boston in September.
  • MediciGlobal CEO will speak at the DIA Rare Diseases and Orphan Products Summit in Washington DC in October.  Also that month, she will chair a workshop at the Patient Recruitment, Compliance and Retention for Clinical Trials Conference in New York City.

    • 2012

  • MediciGlobal CEO will chair the fourth annual Europe conference on Patient Recruitment and Retention in Barcelona, organised by Alan Lloyds.

    •